Peptidomimetic blockade of MYB in acute myeloid leukemia
UID: 10694
Publisher(s): Memorial Sloan Kettering Cancer Center- Description
- Summary from the GEO: "This SuperSeries is composed of the SubSeries: GSE94240, GSE94241, GSE107078"
A potential pharmacological therapeutic strategy for Acute Myeloid Leukemia (AML) was analyzed with the deposited experiments. Using structure-guided molecular design, a prototypical peptidomimetic inhibitor, MYBMIM, was developed and shown to interfere with the molecular assembly of AML cells. MYBMIM may be an effective therapeutic blockade against MYB-driven gene trans-activation with CREB-binding proteins.
The superseries provides access and download of unprocessed data coordinated by sequencing category in the subseries.
-
Access via GEO
BIGWIG file of expression and genome binding/occupancy profiling by high throughput sequencing
Accession #: GSE94242Access via BioProjectAdditional information about the overall initiative.
Accession #: PRJNA369117 - Access Restrictions
-
Free to All
- Access Instructions
- The NCBI Gene Expression Omnibus and BioProject databases provide open access to these files.
- Associated Publications
- Data Type
- Equipment Used
- Dataset Format(s)
- TAR, BIGWIG
- Dataset Size
- 3.7 GB (TAR of BIGWIG)
Do you have or know of a dataset that should be added to the catalog? Let us know!